Novo Holdings, the global healthcare and life sciences investment firm that manages assets for the Novo Nordisk Foundation and is the controlling shareholder of Danish pharma major Novo Nordisk, has acquired a 49 % minority stake in India’s Surya Hospitals a leading women’s and children’s speciality hospital chain headquartered in Maharashtra. The deal, valued at approximately ₹1,000–1,200 crore, marks one of the latest significant foreign investments in India’s burgeoning private healthcare sector.

The investment will support Surya Hospitals’ next phase of growth, including expanding its clinical footprint across Western India, strengthening its specialist medical teams, and building out advanced clinical infrastructure* at its facilities in Mumbai, Pune and Jaipur. Surya Hospitals is widely recognised for its clinical excellence in women’s, neonatal and paediatric care and operates an accredited network delivering comprehensive services in obstetrics, gynae-neonatology and paediatric specialties.

Under the terms of the transaction, Novo Holdings’ senior Asia leadership, including Amit Kakar (Managing Partner and Head of Asia) and Navjeewan Khosla (Partner, Novo Holdings Asia), is expected to join the board of Surya Hospitals, with Hulbert Soh (Principal, Novo Holdings Asia) serving as a board observer — signalling a long-term strategic partnership to enhance governance and clinical impact.

Surya Hospitals, founded in 1984, has built a reputation as one of Western India’s foremost private healthcare providers for maternal and child health, with neonatal survival rates and multidisciplinary care outcomes that have drawn patients from across the region. Novo Holdings said the investment aligns with its broader strategy to back quality healthcare delivery platforms in high-growth markets like India, where rising urbanisation and shifting demographic trends are increasing demand for specialised and outcome-driven care.

Industry analysts say the transaction reflects sustained merger and acquisition activity in India’s hospital sector, following several large deals in recent years, underscoring continued investor confidence in the long-term prospects of healthcare services and clinical excellence in the country.